Clinical Scorecard: Impact of Surgical Stress Response on Long-Term Outcomes in Robot-Assisted Compared to Laparoscopic Colon Cancer Surgery: A Nationwide Cohort Analysis with Propensity Matching

At a Glance

Key Highlights

• Robot-assisted surgery (RAS) is associated with reduced perioperative surgical stress response compared to laparoscopic surgery (LAS).
• Elevated postoperative CRP levels correlate with decreased overall, colorectal-specific, and recurrence-free survival.
• Nationwide cohort study using propensity score matching showed improved long-term survival with RAS versus LAS in colon cancer patients.

Guideline-Based Recommendations

Diagnosis

• Use UICC staging (I–III) to select patients for curative minimally invasive colon cancer surgery.
• Monitor postoperative CRP levels as a biomarker for surgical stress response and potential prognostic indicator.

Management

• Consider robot-assisted surgery to reduce surgical stress response and potentially improve long-term oncological outcomes.
• Exclude emergency surgeries and metastatic disease when planning curative resections.

Monitoring & Follow-up

• Measure postoperative CRP concentrations to assess systemic inflammatory response.
• Use neutrophil–lymphocyte ratio and Glasgow Prognostic Score as additional markers to predict long-term survival.

Risks

• High postoperative CRP response is associated with increased risk of cancer recurrence and mortality.
• Surgical trauma may promote micrometastatic progression via stress hormones and proinflammatory cytokines.

Patient & Prescribing Data

Adults undergoing elective minimally invasive colon cancer surgery for UICC stage I–III disease in Denmark

Robot-assisted surgery may reduce perioperative inflammatory stress and improve long-term survival compared to laparoscopic surgery.

Clinical Best Practices

• Employ propensity score matching in observational studies to reduce treatment assignment bias.
• Utilize national registries and unique patient identifiers for comprehensive data linkage and outcome tracking.
• Apply validated algorithms to define cancer recurrence using multiple registry data sources.
• Monitor postoperative inflammatory biomarkers to guide prognosis and follow-up strategies.

References

• Danish Colorectal Cancer Group Database (DCCG)
• Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement
• Lash et al. algorithm for recurrence identification
• Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM)